SCHEMBL14848979

SCHEMBL14848979

CNCOc1ccc(CC(=O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
POLB P06746 1/20 0.51
PLA2G4B P0C869 1/20 0.50
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
PTGS1 P23219 1/20 0.47
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
CA2 P00918 1/20 0.47
CAMK2A Q9UQM7 1/20 0.47
SRD5A2 P31213 1/20 0.46
PPARD Q03181 2/20 0.46
AKR1B1 P15121 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
PDE4A P27815 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HIF1A Q16665 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11697243 0.83 ALDH1A1 (0.49) KDM4EPOLBPLA2G4BALDH1A1LMNA
SCHEMBL11295734 0.80 PLA2G4B (0.51) KDM4EPOLBPLA2G4BALDH1A1LMNA
SCHEMBL503308 0.79 PLA2G4B (0.58) POLBPLA2G4BALDH1A1CA2CAMK2A
SCHEMBL11683055 0.79 PLA2G4B (0.61) KDM4EPLA2G4BALDH1A1LMNAPTGS1
Hydrochloric Acid SCHEMBL2528810 0.78 PLA2G4B (0.56) KDM4EPOLBPLA2G4BALDH1A1SMN1; SMN2
SCHEMBL14516116 0.78 PKM (0.56) POLBPLA2G4BCA2SMN1; SMN2ALOX15
Dimethylamine SCHEMBL1630099 0.78 KDM4E (0.73) KDM4EPOLBALDH1A1LMNAPTGS1
SCHEMBL5224516 0.77 PLA2G4B (0.56) KDM4EPOLBPLA2G4BALDH1A1LMNA
SCHEMBL11684213 0.77 PLA2G4B (0.69) KDM4EPLA2G4BALDH1A1LMNACA2
SCHEMBL9832704 0.77 ALOX15 (0.63) PLA2G4BALDH1A1CA2CAMK2ASRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140243547-A1 LINEAR (PER) FLUOROPOLYETHERS WITH -CF(CF3)COF END GROUPS AND DERIVATIVES THEREOF SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2014-08-28 US disclosed
US-20140243547-A1 LINEAR (PER) FLUOROPOLYETHERS WITH -CF(CF3)COF END GROUPS AND DERIVATIVES THEREOF SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2014-08-28 US disclosed
WO-2013050273-A1 LINEAR (PER)FLUOROPOLYETHERS WITH -CF(CF3)COF END GROUPS AND DERIVATIVES THEREOF SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2013-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243547-A1 LINEAR (PER) FLUOROPOLYETHERS WITH -CF(CF3)COF END GROUPS AND DERIVATIVES THEREOF COXFA4, CYP4F3, ETFB KDM4E 3068/4885POLB 157/4885PLA2G4B 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.